| Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage … A Gallamini, M Hutchings, L Rigacci, L Specht, F Merli, M Hansen, C Patti, ... Journal of clinical oncology 25 (24), 3746-3752, 2007 | 1024 | 2007 |
| Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project M Federico, M Bellei, L Marcheselli, S Luminari, A Lopez-Guillermo, ... Journal of Clinical Oncology 27 (27), 4555-4562, 2009 | 850 | 2009 |
| Adapted treatment guided by interim PET-CT scan in advanced Hodgkin’s lymphoma P Johnson, M Federico, A Kirkwood, A Fosså, L Berkahn, A Carella, ... New England Journal of Medicine 374 (25), 2419-2429, 2016 | 803 | 2016 |
| Pure red-cell aplasia and epoetin therapy CL Bennett, S Luminari, AR Nissenson, MS Tallman, SA Klinge, ... New England Journal of Medicine 351 (14), 1403-1408, 2004 | 550 | 2004 |
| Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project M Federico, T Rudiger, M Bellei, BN Nathwani, S Luminari, B Coiffier, ... Journal of Clinical Oncology 31 (2), 240, 2013 | 397 | 2013 |
| ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin’s lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei … M Federico, S Luminari, E Iannitto, G Polimeno, L Marcheselli, ... J Clin Oncol 27 (5), 805-811, 2009 | 371 | 2009 |
| The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease A Gallamini, L Rigacci, F Merli, L Nassi, A Bosi, I Capodanno, S Luminari, ... haematologica 91 (4), 475-481, 2006 | 368 | 2006 |
| R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana … M Federico, S Luminari, A Dondi, A Tucci, U Vitolo, L Rigacci, ... Journal of Clinical Oncology 31 (12), 1506-1513, 2013 | 317 | 2013 |
| The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale A Gallamini, SF Barrington, A Biggi, S Chauvie, L Kostakoglu, ... Haematologica 99 (6), 1107, 2014 | 289 | 2014 |
| Baseline metabolic tumor volume predicts outcome in high–tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies M Meignan, AS Cottereau, A Versari, L Chartier, J Dupuis, S Boussetta, ... Journal of Clinical Oncology 34 (30), 3618-3626, 2016 | 288 | 2016 |
| PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study SF Barrington, AA Kirkwood, A Franceschetto, MJ Fulham, TH Roberts, ... Blood, The Journal of the American Society of Hematology 127 (12), 1531-1538, 2016 | 185 | 2016 |
| Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients M Meignan, M Sasanelli, RO Casasnovas, S Luminari, F Fioroni, ... European journal of nuclear medicine and molecular imaging 41, 1113-1122, 2014 | 180 | 2014 |
| High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy M Federico, M Bellei, P Brice, M Brugiatelli, A Nagler, C Gisselbrecht, ... Journal of clinical oncology 21 (12), 2320-2325, 2003 | 178 | 2003 |
| The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi S Luminari, I Biasoli, L Arcaini, A Versari, C Rusconi, F Merli, M Spina, ... Annals of oncology 24 (8), 2108-2112, 2013 | 175 | 2013 |
| Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi L Arcaini, D Vallisa, S Rattotti, VV Ferretti, AJM Ferreri, P Bernuzzi, ... Annals of Oncology 25 (7), 1404-1410, 2014 | 173 | 2014 |
| Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma L Ceriani, M Martelli, PL Zinzani, AJM Ferreri, B Botto, C Stelitano, M Gotti, ... Blood, The Journal of the American Society of Hematology 126 (8), 950-956, 2015 | 171 | 2015 |
| Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies J Trotman, S Luminari, S Boussetta, A Versari, J Dupuis, C Tychyj, ... The Lancet Haematology 1 (1), e17-e27, 2014 | 169 | 2014 |
| Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo … F Merli, S Luminari, F Ilariucci, M Petrini, C Visco, A Ambrosetti, ... British journal of haematology 156 (3), 346-353, 2012 | 159 | 2012 |
| Watchful waiting in low–tumor burden follicular lymphoma in the rituximab era: results of an F2-study database P Solal-Céligny, M Bellei, L Marcheselli, EA Pesce, S Pileri, P McLaughlin, ... Journal of clinical oncology 30 (31), 3848-3853, 2012 | 151 | 2012 |
| Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research … CL Bennett, D Cournoyer, KR Carson, J Rossert, S Luminari, AM Evens, ... Blood 106 (10), 3343-3347, 2005 | 139 | 2005 |
